#Long-Term Impact of Intelligent Monitoring Technology on People with Cognitive Impairment: An Observational Study
1	1	0	9	Long-Term
1	2	10	16	Impact
1	3	17	19	of
1	4	20	31	Intelligent
1	5	32	42	Monitoring
1	6	43	53	Technology
1	7	54	56	on
1	8	57	63	People
1	9	64	68	with
1	10	69	78	Cognitive
1	11	79	89	Impairment
1	12	89	90	:
1	13	91	93	An
1	14	94	107	Observational
1	15	108	113	Study
#BACKGROUND: Interactive smart home systems are particularly useful for people with cognitive impairment.
2	1	114	124	BACKGROUND
2	2	124	125	:
2	3	126	137	Interactive
2	4	138	143	smart
2	5	144	148	home
2	6	149	156	systems
2	7	157	160	are
2	8	161	173	particularly
2	9	174	180	useful
2	10	181	184	for
2	11	185	191	people
2	12	192	196	with
2	13	197	206	cognitive
2	14	207	217	impairment
2	15	217	218	.
#OBJECTIVE: To investigate the long-term effects of Assistive Technology (AT) combined with tailored non-pharmacological interventions for people with cognitive impairment.
3	1	324	333	OBJECTIVE
3	2	333	334	:
3	3	335	337	To
3	4	338	349	investigate
3	5	350	353	the
3	6	354	363	long-term
3	7	364	371	effects
3	8	372	374	of
3	9	375	384	Assistive
3	10	385	395	Technology
3	11	396	397	(
3	12	397	399	AT
3	13	399	400	)
3	14	401	409	combined
3	15	410	414	with
3	16	415	423	tailored
3	17	424	443	non-pharmacological
3	18	444	457	interventions
3	19	458	461	for
3	20	462	468	people
3	21	469	473	with
3	22	474	483	cognitive
3	23	484	494	impairment
3	24	494	495	.
#METHODS: 18 participants (12 with mild cognitive impairment and 6 with Alzheimer's disease) took part in the study that we evenly allocated in one of three groups: 1) experimental group (EG), 2) control group 1 (CG1), and 3) control group 2 (CG2).
4	1	668	675	METHODS
4	2	675	676	:
4	3	677	679	18
4	4	680	692	participants
4	5	693	694	(
4	6	694	696	12
4	7	697	701	with
4	8	702	706	mild
4	9	707	716	cognitive
4	10	717	727	impairment
4	11	728	731	and
4	12	732	733	6
4	13	734	738	with
4	14	739	748	Alzheimer
4	15	748	750	's
4	16	751	758	disease
4	17	758	759	)
4	18	760	764	took
4	19	765	769	part
4	20	770	772	in
4	21	773	776	the
4	22	777	782	study
4	23	783	787	that
4	24	788	790	we
4	25	791	797	evenly
4	26	798	807	allocated
4	27	808	810	in
4	28	811	814	one
4	29	815	817	of
4	30	818	823	three
4	31	824	830	groups
4	32	830	831	:
4	33	832	833	1
4	34	833	834	)
4	35	835	847	experimental
4	36	848	853	group
4	37	854	855	(
4	38	855	857	EG
4	39	857	858	)
4	40	858	859	,
4	41	860	861	2
4	42	861	862	)
4	43	863	870	control
4	44	871	876	group
4	45	877	878	1
4	46	879	880	(
4	47	880	883	CG1
4	48	883	884	)
4	49	884	885	,
4	50	886	889	and
4	51	890	891	3
4	52	891	892	)
4	53	893	900	control
4	54	901	906	group
4	55	907	908	2
4	56	909	910	(
4	57	910	913	CG2
4	58	913	914	)
4	59	914	915	.
#EG received the system installed at home for 4 to 12 months, during which they received tailored non-pharmacological interventions according to system observations.
5	1	1164	1166	EG
5	2	1167	1175	received
5	3	1176	1179	the
5	4	1180	1186	system
5	5	1187	1196	installed
5	6	1197	1199	at
5	7	1200	1204	home
5	8	1205	1208	for
5	9	1209	1210	4
5	10	1211	1213	to
5	11	1214	1216	12
5	12	1217	1223	months
5	13	1223	1224	,
5	14	1225	1231	during
5	15	1232	1237	which
5	16	1238	1242	they
5	17	1243	1251	received
5	18	1252	1260	tailored
5	19	1261	1280	non-pharmacological
5	20	1281	1294	interventions
5	21	1295	1304	according
5	22	1305	1307	to
5	23	1308	1314	system
5	24	1315	1327	observations
5	25	1327	1328	.
#CG1 received tailored interventions for the same period, but only according to state-of-the-art self-reporting methods.
6	1	1494	1497	CG1
6	2	1498	1506	received
6	3	1507	1515	tailored
6	4	1516	1529	interventions
6	5	1530	1533	for
6	6	1534	1537	the
6	7	1538	1542	same
6	8	1543	1549	period
6	9	1549	1550	,
6	10	1551	1554	but
6	11	1555	1559	only
6	12	1560	1569	according
6	13	1570	1572	to
6	14	1573	1589	state-of-the-art
6	15	1590	1604	self-reporting
6	16	1605	1612	methods
6	17	1612	1613	.
#Finally, CG2 neither had a system installation nor received interventions.
7	1	1734	1741	Finally
7	2	1741	1742	,
7	3	1743	1746	CG2
7	4	1747	1754	neither
7	5	1755	1758	had
7	6	1759	1760	a
7	7	1761	1767	system
7	8	1768	1780	installation
7	9	1781	1784	nor
7	10	1785	1793	received
7	11	1794	1807	interventions
7	12	1807	1808	.
#All groups underwent neuropsychological assessment before and after the observational period.
8	1	1884	1887	All
8	2	1888	1894	groups
8	3	1895	1904	underwent
8	4	1905	1923	neuropsychological
8	5	1924	1934	assessment
8	6	1935	1941	before
8	7	1942	1945	and
8	8	1946	1951	after
8	9	1952	1955	the
8	10	1956	1969	observational
8	11	1970	1976	period
8	12	1976	1977	.
#RESULTS: After several months of continuously monitoring at home and deployment of tailored interventions, the EG showed statistically significant improvement in cognitive function, compared to the CG1 and CG2.
9	1	2072	2079	RESULTS
9	2	2079	2080	:
9	3	2081	2086	After
9	4	2087	2094	several
9	5	2095	2101	months
9	6	2102	2104	of
9	7	2105	2117	continuously
9	8	2118	2128	monitoring
9	9	2129	2131	at
9	10	2132	2136	home
9	11	2137	2140	and
9	12	2141	2151	deployment
9	13	2152	2154	of
9	14	2155	2163	tailored
9	15	2164	2177	interventions
9	16	2177	2178	,
9	17	2179	2182	the
9	18	2183	2185	EG
9	19	2186	2192	showed
9	20	2193	2206	statistically
9	21	2207	2218	significant
9	22	2219	2230	improvement
9	23	2231	2233	in
9	24	2234	2243	cognitive
9	25	2244	2252	function
9	26	2252	2253	,
9	27	2254	2262	compared
9	28	2263	2265	to
9	29	2266	2269	the
9	30	2270	2273	CG1
9	31	2274	2277	and
9	32	2278	2281	CG2
9	33	2281	2282	.
#Moreover, EG participants, who received the sensor-based system, have shown improvement in domains such as sleep quality and daily activity, as measured by the multi-sensor system.
10	1	2494	2502	Moreover
10	2	2502	2503	,
10	3	2504	2506	EG
10	4	2507	2519	participants
10	5	2519	2520	,
10	6	2521	2524	who
10	7	2525	2533	received
10	8	2534	2537	the
10	9	2538	2550	sensor-based
10	10	2551	2557	system
10	11	2557	2558	,
10	12	2559	2563	have
10	13	2564	2569	shown
10	14	2570	2581	improvement
10	15	2582	2584	in
10	16	2585	2592	domains
10	17	2593	2597	such
10	18	2598	2600	as
10	19	2601	2606	sleep
10	20	2607	2614	quality
10	21	2615	2618	and
10	22	2619	2624	daily
10	23	2625	2633	activity
10	24	2633	2634	,
10	25	2635	2637	as
10	26	2638	2646	measured
10	27	2647	2649	by
10	28	2650	2653	the
10	29	2654	2666	multi-sensor
10	30	2667	2673	system
10	31	2673	2674	.
#In addition, the feedback collected from the participants concludes that the long-term use of the multi-sensor system by people with cognitive impairment can be both feasible and beneficial.
11	1	2856	2858	In
11	2	2859	2867	addition
11	3	2867	2868	,
11	4	2869	2872	the
11	5	2873	2881	feedback
11	6	2882	2891	collected
11	7	2892	2896	from
11	8	2897	2900	the
11	9	2901	2913	participants
11	10	2914	2923	concludes
11	11	2924	2928	that
11	12	2929	2932	the
11	13	2933	2942	long-term
11	14	2943	2946	use
11	15	2947	2949	of
11	16	2950	2953	the
11	17	2954	2966	multi-sensor
11	18	2967	2973	system
11	19	2974	2976	by
11	20	2977	2983	people
11	21	2984	2988	with
11	22	2989	2998	cognitive
11	23	2999	3009	impairment
11	24	3010	3013	can
11	25	3014	3016	be
11	26	3017	3021	both
11	27	3022	3030	feasible
11	28	3031	3034	and
11	29	3035	3045	beneficial
11	30	3045	3046	.
#CONCLUSION: Deploying a sensor-based system at real home settings of people with cognitive limitations living alone and maintaining its use long-term is not only possible, but also beneficial for clinical decision making in order to tackle cognitive, functional, and behavioral related problems.
12	1	3238	3248	CONCLUSION
12	2	3248	3249	:
12	3	3250	3259	Deploying
12	4	3260	3261	a
12	5	3262	3274	sensor-based
12	6	3275	3281	system
12	7	3282	3284	at
12	8	3285	3289	real
12	9	3290	3294	home
12	10	3295	3303	settings
12	11	3304	3306	of
12	12	3307	3313	people
12	13	3314	3318	with
12	14	3319	3328	cognitive
12	15	3329	3340	limitations
12	16	3341	3347	living
12	17	3348	3353	alone
12	18	3354	3357	and
12	19	3358	3369	maintaining
12	20	3370	3373	its
12	21	3374	3377	use
12	22	3378	3387	long-term
12	23	3388	3390	is
12	24	3391	3394	not
12	25	3395	3399	only
12	26	3400	3408	possible
12	27	3408	3409	,
12	28	3410	3413	but
12	29	3414	3418	also
12	30	3419	3429	beneficial
12	31	3430	3433	for
12	32	3434	3442	clinical
12	33	3443	3451	decision
12	34	3452	3458	making
12	35	3459	3461	in
12	36	3462	3467	order
12	37	3468	3470	to
12	38	3471	3477	tackle
12	39	3478	3487	cognitive
12	40	3487	3488	,
12	41	3489	3499	functional
12	42	3499	3500	,
12	43	3501	3504	and
12	44	3505	3515	behavioral
12	45	3516	3523	related
12	46	3524	3532	problems
12	47	3532	3533	.
